Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Mycoplasma Testing Market Size Outlook: How Fast Will Revenue Grow Through 2030?
Exhibit A presents a compelling trajectory for the mycoplasma testing market, projecting an expansion from $1.23 billion in 2025 to $1.38 billion by 2026, reflecting a robust compound annual growth rate (CAGR) of 12.1%. This notable growth during the preceding period was fueled by a confluence of factors, including a high incidence of mycoplasma contamination, a burgeoning dependence on cell culture methodologies, escalating demand for diagnostic procedures, the swift integration of PCR techniques, and the increasing deployment of ELISA methods.
The mycoplasma testing sector is projected for swift expansion in the upcoming years, anticipating a market valuation of $2.1 billion by 2030 with a compound annual growth rate of 11.1%. This projected uplift is fueled by several key drivers: an increase in biopharmaceutical production activities, an upswing in contract research outsourcing, heightened financial commitment to genomic analysis, a growing focus from regulatory bodies on preventing contamination, and the wider integration of automated testing solutions. Key developments anticipated during this forecast period involve a greater embrace of polymerase chain reaction (PCR) based mycoplasma identification methods, augmented utilization of rapid testing kits for cell culture surveillance, escalating demand for automated mycoplasma detection apparatus, broadened application of assays and reagents within biopharmaceutical manufacturing processes, and an increased necessity for mycoplasma testing in both research and contract research organization environments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp
Mycoplasma Testing Market Growth Drivers And Industry Catalysts
The expanding incidence of mycoplasma pneumonia is poised to invigorate the expansion of the mycoplasma testing market in the foreseeable future. Mycoplasma pneumonia is characterized as an infection affecting the respiratory system, stemming from the Mycoplasma pneumoniae bacteria. Within the diagnostic process for Mycoplasma pneumonia, mycoplasma testing serves a vital function by identifying Mycoplasma pneumoniae in samples from the respiratory tract, thereby facilitating prompt and precise detection of the illness for effective medical intervention and care. To illustrate, data from the Centers for Disease Control and Prevention, a governmental body in the United States, indicated in December 2023 that approximately 2 million instances of Mycoplasma pneumoniae infections are reported annually across the United States. Consequently, the heightened occurrence of mycoplasma pneumonia is a key factor fueling the expansion of the mycoplasma testing market.
Mycoplasma Testing Market Segment Breakdown: Which Categories Generate The Most Revenue?
The mycoplasma testing market covered in this report is segmented –
1) By Product: Instruments, Assay, Kits, Reagents
2) By Technology: PCR, Elisa, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell Line Testing, Virus Testing, End- Of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks And Laboratories, Contract Research Organizations, Academic Research Institutes
Subsegments:
1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment
2) By Assay: Mycoplasma Assays, Qualitative Assays, Quantitative Assays
3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits For Cell Cultures, Sample Preparation Kits
4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents
#Mycoplasma Testing Market Trends Influencing Long-Term Demand
Leading players within the mycoplasma testing sector are prioritizing the development and release of digital PCR kits, a strategic move aimed at enhancing their market positioning. Digital PCR kits, essentially advanced molecular biology instruments, facilitate the exact measurement and examination of genetic materials like DNA or RNA through a digital methodology. As an illustration, by November 2023, QIAGEN, a prominent diagnostics firm headquartered in Germany, introduced three novel QIAcuity digital PCR kits alongside enhanced software, broadening the accessibility of digital PCR’s capabilities for biopharmaceutical research and food safety evaluations. These newly developed QIAcuity kits are engineered for superior accuracy in quantification and come in configurations supporting one, four, and eight plates; notably, the single-plate variant possesses the capacity to analyze as many as 384 samples within an eight-hour timeframe. Among the recent introductions is the QIAcuity Mycoplasma Quant Kit, which furnishes researchers with a highly accurate and dependable method for identifying mycoplasma contamination throughout various research phases.
Mycoplasma Testing Market Key Players And Strategic Industry Positioning
Major companies operating in the mycoplasma testing market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.
Access The Complete Mycoplasma Testing Market Report:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report
Mycoplasma Testing Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the mycoplasma testing market in 2025. Asia-Pacificis expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
